0001214659-21-005926.txt : 20210526 0001214659-21-005926.hdr.sgml : 20210526 20210526080015 ACCESSION NUMBER: 0001214659-21-005926 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210524 FILED AS OF DATE: 20210526 DATE AS OF CHANGE: 20210526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHMIDT ERIC THOMAS CENTRAL INDEX KEY: 0001754403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 21962755 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-52930.xml PRIMARY DOCUMENT X0306 4 2021-05-24 0001737287 Allogene Therapeutics, Inc. ALLO 0001754403 SCHMIDT ERIC THOMAS 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Financial Officer Common Stock 2021-05-24 4 M false 14897 18.22 A 110994 D Common Stock 1152595 I See footnote Stock Option (Right to Buy) 18.22 2021-05-24 4 M false 14897 0.00 D 2030-03-18 Common Stock 14897 94703 D The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust. 25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/ Veer Bhavnagri, Attorney-in-Fact 2021-05-24